Indeed, ALZUMAb® (Itolizumab), a humanized anti-human CD6 mAb developed from its parent murine antibody IOR-T1, has been approved by the Drugs Controller General of India in January 2013 to treat psoriasis [120,121]. The gene discussed is CD6; the disease is psoriasis.